Retrospective Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Feb 16, 2022; 10(5): 1536-1547
Published online Feb 16, 2022. doi: 10.12998/wjcc.v10.i5.1536
Figure 1
Figure 1 Distribution of enlarged lymph nodes in patients unicentric Castleman disease (n = 18).
Figure 2
Figure 2 Relationship between unicentric Castleman disease clinical manifestations and pathological classification (n = 18). *Complications include paraneoplastic pemphigus, malignant tumor, bronchiolitis obliterans, etc.
Figure 3
Figure 3 Comparison of clinical manifestations between TAFRO syndrome (n = 8) and idiopathic multicentric Castleman disease-not otherwise specified (n = 13).
Figure 4
Figure 4 Comparison of pathological classification of TAFRO syndrome (n = 8) and idiopathic multicentric Castleman disease-not otherwise specified (n = 13).
Figure 5
Figure 5 Comparison of distribution of lymph node pathological results in patients with idiopathic multicentric Castleman disease.